Skip to main content
. 2016 Mar;4(3):E301–E308. doi: 10.1055/s-0042-101786

Table 1. Summary of Crohn’s disease patients reported in the literature with SEMS.

Author/Year Nº of patients Location Length Previous treatment Stent type Technical/Clinical success (rate1) Durantion of stenting Outcome
Matsuhashi 1997 /2000 17  2 Colon EBD FCSEMS (15 × 50 mm) Yes/Yes 4 w (SM) Symptom free at 3 years
IC anastomosis EBD 3 FCSEMS? Yes/Yes 22 w (SM) Symptom free at 4.5 years
Whole 1998 18  1 colon No TB-UC Yes/Yes 3 w BS2
Suzuki 2004 19  2 Colon UCSEMS Yes/No 13 w Fistula terminal ileum → surgery
2 UCSEMS Yes/Yes 104 w Recurrence → stent
Wada 2005 20  1 Colon No UCSEMS Yes/Yes 139 w Perforation and fistula
Bickston 2005 21  1 Ileocecal EBD 2 UCSEMS (10x60 mm) Yes/Yes 8 w Symptom free at 2 months
Dafnis 2007 22  1 Colon 5 cm No 4 UCSEMS (22x90 mm) Yes/Yes 82 w Death from lung cancer
Martines 2008 23  1 IC anastomosis 6 cm EBD FCSEMS (18 /24x80 mm) Yes/Yes 1 w BS2
Small 2008 24  1 Rectum No 2 PCSEMS (30x117 – 57) Yes/Yes 1 w BS2
Keranen 2010 25  2 Anastomosis No FCSEMS Yes/Yes 6 w BS2
UCSEMS Yes/Yes 221 w Perforation
Levin 2012 26  5 IC anastomosis < 6 cm EBD (2 patients) UCSEMS Yes (100 %)/Yes (80 %) 3 w – 9 years Symptom free in 4 /5 patients
Attar 2012 27 11 IC anastomosis(9 patients)/Terminal ileum (2 patients) 1 – 4 cm EBD (9 patients) FCSEMS Yes (90 %)/Yes (36 %) 1 – 28 days (8 stents SM) Symptom free in 4 /11 patients ≥ 1 year. 2 complications
Branche 201228 7 IC anastomosis  < 5 cm EBD PCSEMS Yes (100 %)/Yes (71,4 %) 1 w Symptom free in 5/7 patients, mean follow-up 10 months.
Loras 2012 29 17 IC anastomosis (10 patients)/colon (7 patients)  < 8 cm EBD (14 patients) PCSEMS (4)/FCSEMS (21) Yes (92 %)/Yes (64.7 %) Mean 28 days (1 – 112) (13 stents SM) Symptom free in 11/17 patients, mean follow-up 67 w. 1 complication.

Abbreviations: C, ileocolonic; EBD, endoscopic balloon dilatation; FCSEMS, fully covered self-expanding metal stent; UCSEMS, uncovered self-expanding metal stent; PCSEMS, partially covered self-expanding metal stent; TB, tracheo-bronchial; SM, spontaneous migration.

1

Rate** when is applicable.

2

BS*, bridge to surgery; w, weeks